The 9,600 Missed Diagnoses: How Geography Still Shapes Breast Cancer Outcomes
Despite improvements over the past few decades in breast cancer detection and care, an important new report says that 9,600 early-stage detections are being missed annually in the U.S.
Ten years ago, the results of this new Milken Institute report would have been unsurprising. But after a decade of attention, resources, and federal funding and policy focused on that breast cancer, there are still barriers to adoption. And it’s not what you might think.
The report - which is well worth a read over the weekend - emphasizes that population density, and ultimately, your zip code, are still determinants of healthcare access and outcomes. The study used the location of mammography machines in the U.S. to help predict areas that could use greater focus to ensure greater early detection of breast cancer.
First, some context:
Breast cancer is one of the leading causes of death in the U.S., expected to impact 42,000 women per year. In the past few decades, significant work has been done to ensure earlier detection. The Affordable Care Act helped by making it a covered preventative care service for women over the age of 40 – requiring private insurers and Medicare to cover the costs.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
Peptide Therapy: Where Do We Go From Here?
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health,
Not everyone can access the top 1% of physicians. Will AI change that?
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?
Privacy AI and the Future of HIPAA
Watch the Full Webinar As AI reshapes healthcare and more patient data flows beyond traditional clinical settings, the rules governing privacy, access,
What will AI do for employer healthcare and benefits?
Employer healthcare may be one of the most practical — and overlooked — proving grounds for AI.
Hospitals as the new go-to-market, lessons from the trenches
Watch the Full Webinar Health systems are entering a new frontier, one where innovation isn’t optional, and meaningful change requires creativity,